LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 16

Search options

  1. Article ; Online: Corona viruses: reaching far beyond the common cold.

    Coerdt, Kathleen M / Khachemoune, Amor

    African health sciences

    2021  Volume 21, Issue 1, Page(s) 207–213

    Abstract: Background: Human coronaviruses (HCoVs) are one of the most common causes of the "common cold". Some HCoV strains, however, can cause fatal respiratory disease. Some examples of these diseases are severe acute respiratory syndrome (SARS), Middle East ... ...

    Abstract Background: Human coronaviruses (HCoVs) are one of the most common causes of the "common cold". Some HCoV strains, however, can cause fatal respiratory disease. Some examples of these diseases are severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and Coronavirus Disease 19 (COVID-19). This article will review the etiology, clinical features, diagnosis, and management of HCoVs.
    Methods: A systematic literature review was performed using the terms "human coronaviruses", "MERS-CoV", "SARSCoV", "SARS-CoV2", "COVID-19", and "common cold" in OVID MEDLINE, PubMed, and Cochrane Library.
    Findings: Most HCoVs cause mild upper respiratory infections which resolve with supportive care and no sequelae. In recent decades, however, there have been outbreaks of novel HCoVs that cause more severe disease. This is largely due to HCoVs having large genomes which undergo frequent recombination events, leading to the emergence of novel and more virulent strains of the virus. These severe respiratory illnesses can lead to acute respiratory distress requiring invasive intervention, such as mechanical ventilation. These severe infections can lead to long-lasting sequelae in patients. Scientists continue to investigate potential treatments for these viruses, though supportive care remains the gold standard. Scientists have succeeded in developing numerous vaccines for the SARS-CoV-2 virus, and ongoing data collection and analysis will shed even more light on the next steps in fighting the COVID-19 pandemic.
    Conclusion: Due to the frequency of recombination events and the subsequent emergence of novel strains, HCoVs are becoming more prevalent, making them a global health concern as they can lead to epidemics and pandemics. Understanding the epidemiology, etiology, clinical features, diagnosis, and management of HCoVs is important, especially during this worldwide pandemic.
    MeSH term(s) COVID-19/diagnosis ; COVID-19/epidemiology ; Common Cold ; Coronavirus ; Disease Outbreaks ; Humans ; Pandemics ; SARS-CoV-2
    Language English
    Publishing date 2021-07-30
    Publishing country Uganda
    Document type Journal Article ; Systematic Review
    ZDB-ID 2240308-5
    ISSN 1729-0503 ; 1680-6905
    ISSN (online) 1729-0503
    ISSN 1680-6905
    DOI 10.4314/ahs.v21i1.27
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Vibrio vulnificus: Review of Mild to Life-threatening Skin Infections.

    Coerdt, Kathleen M / Khachemoune, Amor

    Cutis

    2021  Volume 107, Issue 2, Page(s) E12–E17

    Abstract: Vibrio vulnificus is a motile, gram-negative, halophilic, aquatic bacterium that is part of the normal estuarine microbiome and typically is found in warm coastal waters. Infection with the pathogen typically is due to consumption of contaminated seafood ...

    Abstract Vibrio vulnificus is a motile, gram-negative, halophilic, aquatic bacterium that is part of the normal estuarine microbiome and typically is found in warm coastal waters. Infection with the pathogen typically is due to consumption of contaminated seafood or exposure to contaminated seawater. Vibrio vulnificus has a mortality rate of almost 33% in the United States and is responsible for more than 95% of seafood-related deaths in the United States. Vibrio vulnificus can cause a vast spectrum of diseases, such as gastroenteritis, cellulitis, necrotizing fasciitis, and sepsis. Gastroenteritis is self-limited, whereas septicemia often is fatal. Gastroenteritis and septicemia are caused by ingestion of contaminated shellfish, whereas wound infections and necrotizing fasciitis are caused by exposure to contaminated seawater or handling of contaminated seafood. Septicemia is the most common presentation of V vulnificus and accounts for the most fatalities from the bacteria. Prompt diagnosis and treatment are vital to prevent mortality. It is important to keep V vulnificus on the differential when a patient presents with bullae or cellulitis or has a history of raw seafood consumption or exposure to brackish water, as missing the diagnosis could lead to necrotizing fasciitis, sepsis, and death.
    MeSH term(s) Cellulitis/diagnosis ; Cellulitis/therapy ; Fasciitis, Necrotizing/diagnosis ; Fasciitis, Necrotizing/epidemiology ; Fasciitis, Necrotizing/therapy ; Humans ; Sepsis ; Vibrio Infections/diagnosis ; Vibrio Infections/epidemiology ; Vibrio Infections/therapy ; Vibrio vulnificus
    Language English
    Publishing date 2021-05-12
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 391840-3
    ISSN 2326-6929 ; 0011-4162 ; 0151-9522
    ISSN (online) 2326-6929
    ISSN 0011-4162 ; 0151-9522
    DOI 10.12788/cutis.0183
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Making the world's skin crawl: dermatologic implications of COVID-19.

    Coerdt, Kathleen M / Khachemoune, Amor

    Cutis

    2020  Volume 105, Issue 6, Page(s) 306–308

    MeSH term(s) Betacoronavirus ; COVID-19 ; Coronavirus ; Coronavirus Infections ; Cross Infection ; Dermatology ; Humans ; Pandemics ; Pneumonia, Viral ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-07-27
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 391840-3
    ISSN 2326-6929 ; 0011-4162 ; 0151-9522
    ISSN (online) 2326-6929
    ISSN 0011-4162 ; 0151-9522
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: What is the ulcerated pink nodule on this patient's scalp?

    Coerdt, Kathleen M / Khachemoune, Amor

    JAAPA : official journal of the American Academy of Physician Assistants

    2020  Volume 33, Issue 8, Page(s) 55–56

    MeSH term(s) Aged ; Antigens, CD/analysis ; Antigens, Differentiation, Myelomonocytic/analysis ; Biomarkers/analysis ; Biopsy ; Dermatologic Surgical Procedures/methods ; Diagnosis, Differential ; Humans ; Ki-67 Antigen/analysis ; Male ; Mohs Surgery/methods ; Scalp/pathology ; Scalp/surgery ; Skin/pathology ; Skin Diseases/diagnosis ; Skin Diseases/pathology ; Skin Diseases/surgery ; Skin Pigmentation ; Xanthomatosis/diagnosis ; Xanthomatosis/pathology ; Xanthomatosis/surgery
    Chemical Substances Antigens, CD ; Antigens, Differentiation, Myelomonocytic ; Biomarkers ; CD68 antigen, human ; Ki-67 Antigen ; MKI67 protein, human
    Language English
    Publishing date 2020-07-21
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 2415226-2
    ISSN 0893-7400 ; 1547-1896
    ISSN (online) 0893-7400
    ISSN 1547-1896
    DOI 10.1097/01.JAA.0000684144.71148.80
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Vitamins A, B, C, and D: A Short Review for the Dermatologist.

    Coerdt, Kathleen M / Goggins, Clare A / Khachemoune, Amor

    Alternative therapies in health and medicine

    2020  Volume 27, Issue 4, Page(s) 41–49

    Abstract: Background: Vitamins and their derivatives are used extensively in the field of dermatology to treat a range of conditions, both benign and malignant. Additionally, over the past decade, vitamin supplements have been heavily advertised for improving ... ...

    Abstract Background: Vitamins and their derivatives are used extensively in the field of dermatology to treat a range of conditions, both benign and malignant. Additionally, over the past decade, vitamin supplements have been heavily advertised for improving overall health. Due to the widespread use of vitamins and their derivatives for dermatologic conditions, a comprehensive review of the evidence is needed.
    Objective: Here we review several of the well-established uses of vitamins A, B, C, and D in the management of dermatologic conditions ranging from acne vulgaris to malignant melanoma. Additionally, we examine the dermatologic consequences of both deficiency and excess of vitamins A, B, C, and D. Finally, we delve into newer applications for these vitamins and evaluate the evidence behind them.
    Conclusion: Vitamins, in both topical and oral forms, play a key role in treating many dermatologic conditions. Some of the newer applications of vitamins, such as the use of vitamin B3 for non-melanoma skin cancer prevention, vitamin B6 for prevention of chemotherapy-induced alopecia, and vitamin C as an adjuvant treatment for malignant melanoma, appear promising. Further data is needed to validate these findings. Additionally, many people use vitamin B7 for hair, skin, and nail health. There is evidence that supports vitamin B7 supplementation in patients with uncombable hair syndrome, brittle nail syndrome, and seborrheic dermatitis. Some studies Some studies have also demonstrated a benefit in healthy individuals, although other studies have shown a neutral effect. Further randomized controlled trials are needed. Likewise, the use of vitamin D for the treatment of atopic dermatitis has conflicting results and requires further investigation. New research continues to emerge regarding vitamin supplementation, and it is an important topic for dermatologists.
    MeSH term(s) Ascorbic Acid ; Dermatologists ; Dietary Supplements ; Humans ; Vitamin A/therapeutic use ; Vitamin D ; Vitamins/therapeutic use
    Chemical Substances Vitamins ; Vitamin A (11103-57-4) ; Vitamin D (1406-16-2) ; Ascorbic Acid (PQ6CK8PD0R)
    Language English
    Publishing date 2020-11-27
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1225073-9
    ISSN 1078-6791
    ISSN 1078-6791
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The case of missing skin: Congenital Volkmann ischemic contracture.

    Coerdt, Kathleen M / Guo, Emily L / Saardi, Karl M / Habeshian, Kaiane A

    Pediatric dermatology

    2020  Volume 37, Issue 4, Page(s) 762–763

    Abstract: Congenital Volkmann ischemic contracture (CVIC) is an exceedingly rare neonatal compartment syndrome caused by intrauterine ischemia and external compression. It presents at birth with necrotic cutaneous lesions and neurologic impairment, typically in a ... ...

    Abstract Congenital Volkmann ischemic contracture (CVIC) is an exceedingly rare neonatal compartment syndrome caused by intrauterine ischemia and external compression. It presents at birth with necrotic cutaneous lesions and neurologic impairment, typically in a distal upper extremity. Diagnosis and treatment are often delayed in neonates, leading to long-term neurologic sequelae. We present a rare case of CVIC in order to raise awareness of its presentation and management in hopes of improving outcomes.
    MeSH term(s) Compartment Syndromes ; Humans ; Infant, Newborn ; Ischemic Contracture/diagnosis ; Skin ; Skin Diseases
    Language English
    Publishing date 2020-04-17
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 605539-4
    ISSN 1525-1470 ; 0736-8046
    ISSN (online) 1525-1470
    ISSN 0736-8046
    DOI 10.1111/pde.14177
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Topical rapamycin for acanthosis nigricans in the Fitzpatrick IV/V adolescent population.

    Coerdt, Kathleen M / Todd, Sarah P / DeKlotz, Cynthia M C

    Pediatric dermatology

    2020  Volume 38, Issue 1, Page(s) 296–298

    Abstract: Dermatologically, FGFR3 mutations can lead to acanthosis nigricans (AN), epidermal nevi, and seborrheic keratosis. A recent case report found that topical rapamycin (sirolimus) can improve FGFR3-induced epidermal nevi with AN features in children, ... ...

    Abstract Dermatologically, FGFR3 mutations can lead to acanthosis nigricans (AN), epidermal nevi, and seborrheic keratosis. A recent case report found that topical rapamycin (sirolimus) can improve FGFR3-induced epidermal nevi with AN features in children, specifically with Fitzpatrick skin type (FST) I/II, and we would like to expand these findings to skin plaques with extensive AN-like features in the FST IV/V adolescent population. An 18-year-old female with FST IV/V and FGFR3-induced hypochondroplasia presented to our clinic with extensive AN-like plaques. Significant improvement with lightening and thinning of the plaques was observed after applying 1% topical rapamycin cream twice daily. Topical rapamycin should be considered as a treatment option for AN, particularly in FST IV/V adolescents with FGFR3-induced AN.
    MeSH term(s) Acanthosis Nigricans/diagnosis ; Acanthosis Nigricans/drug therapy ; Adolescent ; Child ; Dwarfism ; Female ; Humans ; Nevus ; Sirolimus/therapeutic use ; Skin Neoplasms
    Chemical Substances Sirolimus (W36ZG6FT64)
    Language English
    Publishing date 2020-10-24
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 605539-4
    ISSN 1525-1470 ; 0736-8046
    ISSN (online) 1525-1470
    ISSN 0736-8046
    DOI 10.1111/pde.14404
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Clinical recommendations made in dermatology publications are frequently not supported by adequate evidence.

    Coerdt, Kathleen M / Haidari, Wasim / Huang, William W / Feldman, Steven R

    The Journal of dermatological treatment

    2020  Volume 32, Issue 7, Page(s) 860–861

    Abstract: Objectives: Absolute risk and cost-benefit analyses are necessary to guide clinical decision making. The purpose of this study was to evaluate whether clinical recommendations in dermatology publications were supported by adequate evidence. We also ... ...

    Abstract Objectives: Absolute risk and cost-benefit analyses are necessary to guide clinical decision making. The purpose of this study was to evaluate whether clinical recommendations in dermatology publications were supported by adequate evidence. We also assessed whether dermatology residents report sufficient evidence when they author publications.
    Methods: We analyzed the clinical cohort, case-control, and case series studies published in JAMA Dermatology and the Journal of American Academy of Dermatology from January 2018 to December 2018 for statistical significance, absolute associations, diagnostic and therapeutic clinical recommendations, and risk-benefit analysis. We also identified articles with a U.S. dermatology resident as first or second author.
    Results: We found that the majority of articles reported statistical significance, but only 3% included absolute risk analyses and none had risk-benefit analysis. Furthermore, 42% of studies with a dermatology resident as a primary author reported statistical significance, but none provided absolute risk or risk-benefit analyses.
    Conclusions: Reviewers need to be more aware of the evidentiary needs required for clinical recommendations, and dermatology residents may benefit from additional statistics training.
    MeSH term(s) Case-Control Studies ; Cost-Benefit Analysis ; Dermatology ; Humans ; United States
    Language English
    Publishing date 2020-01-06
    Publishing country England
    Document type Journal Article
    ZDB-ID 1036299-x
    ISSN 1471-1753 ; 0954-6634
    ISSN (online) 1471-1753
    ISSN 0954-6634
    DOI 10.1080/09546634.2019.1708247
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Hydrogen Peroxide 40% for the Treatment of Seborrheic Keratoses.

    Funkhouser, Colton H / Coerdt, Kathleen M / Haidari, Wasim / Cardis, Michael A

    The Annals of pharmacotherapy

    2020  Volume 55, Issue 2, Page(s) 216–221

    Abstract: Objective: Hydrogen peroxide 40% (HP40) was approved by the US Food and Drug Administration for topical treatment of seborrheic keratosis (SK) in December 2017. This article will review phase II and III clinical trials to assess the drug's efficacy, ... ...

    Abstract Objective: Hydrogen peroxide 40% (HP40) was approved by the US Food and Drug Administration for topical treatment of seborrheic keratosis (SK) in December 2017. This article will review phase II and III clinical trials to assess the drug's efficacy, safety, and clinical application.
    Data sources: A systematic literature review was performed using the terms "Eskata AND seborrheic keratosis," and "hydrogen peroxide AND seborrheic keratosis" in the OVID MEDLINE, PubMed, Cochrane Library, EMBASE, and Web of Science databases. ClinicalTrials.gov was searched to identify ongoing or nonpublished studies.
    Study selection and data abstraction: Articles written in English between January 2000 and mid-June 2020 discussing phase II and phase III clinical trials were evaluated.
    Data synthesis: In 2 phase III clinical trials, 4% and 8% of patients treated with HP40 had a Physician Lesion Assessment score of zero for all 4 SKs, respectively, compared with 0% in both vehicle groups at the primary end point of day 106 (
    Relevance to patient care and clinical practice: HP40, although less effective, has a better safety profile than other treatment options. It should be especially considered for treatment of facial SKs, where it is most efficacious and where other treatment modalities, such as cryotherapy, are more challenging.
    Conclusions: HP40 is a new, safe alternative treatment for SKs, although it is expensive and only modestly effective, both of which somewhat limit its overall utility. HP40 is a promising topical alternative, particularly for cosmetically sensitive locations, such as the face.
    MeSH term(s) Administration, Topical ; Clinical Trials, Phase II as Topic ; Clinical Trials, Phase III as Topic ; Female ; Humans ; Hydrogen Peroxide/administration & dosage ; Hydrogen Peroxide/adverse effects ; Hydrogen Peroxide/therapeutic use ; Keratosis, Seborrheic/drug therapy ; Keratosis, Seborrheic/pathology ; Oxidants/administration & dosage ; Oxidants/adverse effects ; Oxidants/therapeutic use ; Randomized Controlled Trials as Topic ; Treatment Outcome ; United States ; United States Food and Drug Administration
    Chemical Substances Oxidants ; Hydrogen Peroxide (BBX060AN9V)
    Language English
    Publishing date 2020-07-10
    Publishing country United States
    Document type Journal Article ; Systematic Review
    ZDB-ID 1101370-9
    ISSN 1542-6270 ; 1060-0280
    ISSN (online) 1542-6270
    ISSN 1060-0280
    DOI 10.1177/1060028020941793
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top